The present invention relates generally to prosthetic devices, in particular, to articulated endoprosthetic devices, such as those suitable for implantation in skeletal joints.
The need for endoprostheses (prostheses that are implantable) in human joints may arise from degeneration of the joint due to disease or wear, or as the result of fracture of one or more bones forming the joint. The endoprosthesis replaces one or more elements of the joint, frequently providing an artificial surface to bear against another element of the joint, or an element of the prosthesis.
Because many endoprosthesis designs involve surfaces that articulate with respect to each other, these surfaces are subject to wear, i.e., to removal of material from the surfaces as the result of contact with, and movement with respect to, other surfaces in the joint. This wear can generate material known as “wear debris,” which are small particles of material that, in some cases cause health problems if released into the body. Some wear debris results from normal contact between surfaces of an articulating endoprosthesis during conditions of use, such as movement between the bearing surfaces of the endoprosthesis. Wear debris can also result from impact between elements of the endoprosthesis, either during normal use conditions, or during more extreme conditions, such as conditions subjecting the joint to unusual movement or shocks. Wear debris can also result from frequent movement of the endoprosthesis beyond its designed range of motion and from multiple components wearing against each other.
Wear debris particles can be found in macrophages (if the debris particles are small enough in size), or in tissue near or around the prosthesis. Inflammatory tissue responses to wear debris (perhaps enabled by inflammatory mediators released by the macrophages) are believed to contribute to bone resorption and some forms of prosthetic loosening, and thus to the resulting need for revision surgery. The amount and type of wear debris generated by various endoprosthesis designs is a parameter that is evaluated in assessing whether such designs should be approved for use.
The degree to which a design may generate wear debris is therefore a parameter that must be balanced against other design considerations for the device. These include materials biocompatibility, mechanical/physical properties, geometry of the endoprosthesis, manufacturing considerations, and the like.
It is also desirable to allow the endoprosthesis to withstand heavy loading while retaining excellent wear and load supporting characteristics, inter alia, in order to make the design more suitable for use in the lumbar region of the spine, where loads are significantly higher than in the cervical spine.
This invention relates to a body member for an implantable endoprosthesis. In one embodiment, the implantable endoprosthesis is adapted to articulate with one or more prosthesis surfaces, which is at least partially formed from a material having high wear resistance, which may be a polymeric material, such as ultra-high molecular weight polyethylene (UHMWPE), which may be crosslinked or uncrosslinked, polyetherether ketone (PEEK), and the like, or a metallic material, such as a cobalt-chrome alloy, or a ceramic material, such as alumina or zirconia.
In another embodiment, the body member of the endoprosthesis may be formed from a composite material, and contains at least a first component formed from a first material, which has increased wear resistance as compared to that of a second material forming a second component of the body member. The second material is generally more resilient (i.e., has greater elasticity, increased damping, or both) as compared to the first material. The first material is also typically more lubricious and often harder than the second material.
In a specific embodiment, the body member is composed of two materials having a central component formed from the second material disposed between two outer components formed from the first material.
In another specific embodiment, the body member is a composite material having a central component formed from the first material disposed between or around at least one outer component formed from the second material. Additional layers of a wear resistant material, e.g., additional layers of the first material or another material more wear resistant than the second material, can be disposed on one or more outer surfaces of the second material.
The embodiments allow for the construction of an implantable endoprosthesis having one or more elements that articulate relative to the body member of the endoprosthesis such that the surfaces of the body member that have the highest degree of moving contact with other surfaces (and thus more likely to encounter conditions that can generate wear debris) have a high lubricity and wear resistance. Portions of the body member unlikely to encounter significant contact and motion with other endoprosthetic surfaces can be chosen from among materials that provide high resiliency (high elasticity and/or damping).
The invention also relates to a surgical procedure and instruments for implanting the endoprosthesis of the invention, and to a method of implanting an endoprosthesis into a joint, including: obtaining surgical access to the interior of the joint, preparing the interior of the joint to receive an implantable endoprosthesis, introducing the implantable endoprosthesis described above into the interior of the joint.
The invention can be more clearly understood by reference to the drawings as described below. The drawings are intended to be illustrative, and not limiting, of the scope of the invention.
In one embodiment of the invention, the central body of the endoprosthesis contains a first component, formed from a first material having higher wear resistance than a second material, which forms a second component of the body member of the endoprosthesis. The second material will generally have a higher resiliency or elasticity than the first material.
In general, the first material will be harder than the second material, as harder materials tend to have better wear resistance than softer materials. In addition, the first material will tend to be very lubricious, typically as lubricious or more lubricious than the second material. However, hardness is not an absolute prerequisite to increased wear resistance, which can result from a number of different factors. It is possible for the two materials to have similar hardnesses, but very different wear resistances, due to other factors such as lubricity, grain structure, wettability, and the like.
In effect, the first material is used to form one or more components of the body member of the endoprosthesis that are designed to contact other elements of the endoprosthesis during articulation. This contact has the potential to generate wear debris, and this potential is decreased by employing the wear resistant first material at the articulation surfaces of the body member.
In general, the second material has high resiliency, and is used to form other components of the body member where high wear resistance is not as critical, because the likelihood of contact with other surfaces under is low. The second material provides beneficial elasticity and dampening effects to the endoprosthesis, and absorbs compressive and shear forces encountered by the endoprosthesis after implantation. In addition, the second material can be used in areas of the endoprosthesis that are likely to undergo vibration or impact with other elements of the endoprosthesis, but unlikely to experience surface, articulating wear. The higher resiliency and generally lower hardness of the second material can decrease the level of wear debris generated from impact.
The first material may be selected from a range of biocompatible materials that provide resistance to formation of wear debris under conditions that the endoprosthesis will encounter after implantation. Suitable materials will, of necessity, depend somewhat on the geometry of the endoprosthesis, the materials selected for other endoprosthesis components (in particular those that will articulate with the body member of the endoprosthesis), the magnitude and/or direction of stresses expected to be encountered by the endoprosthesis, and other factors.
In a particular embodiment, the endoprosthesis contains a central body disposed between two endplates or “shells” that articulate with respect to the central body. The shells may be formed of metals, polymeric materials, ceramics, or combinations thereof. The shells are formed so as to contact the existing elements of the joint, in particular, the ends of the bones of the joint, in a way that the shells are substantially immobilized with respect to the bones of the joint. The bones and the attached shells move together with respect to the central body as the shells articulate with respect to the central body. As an example, the shells can be formed from titanium or other biocompatible metal or alloy, and may have a porous coating formed on one or more outer surfaces thereof, so as to promote fixation via bone growth into the porous coating.
Desirably, the inner surfaces of the shells have been treated to make them smooth, increase their lubricity, or both. For example, the interior surfaces may be polished, coated, or comprise inserts of material different from the remainder of the shell, in order to provide a smooth, wear resistant surface and decrease the likelihood of generating wear debris during articulation.
In this embodiment, the first material may be any material that will exhibit high wear resistance during contact with elements of the shell. Examples include polymeric materials having molecular weights ranging from about 5.0×10E5 grams/mol to about 6.0×10E6 grams/mol more particularly about 4.0×10E6 grams/mol, modulus of elasticity ranging from about 0.7 to about 3.0 GPa, and cross linking density ranging from 0 to about 50% (as measured by the swell ratio). Examples of such polymers include ultra-high molecular weight polyethylene (UHMWPE), which may be crosslinked or uncrosslinked, polyetherether ketone (PEEK), and the like. Other examples include metallic materials, such as cobalt-chrome alloys, and ceramic materials, such as alumina or zirconia.
The second material, as used in this embodiment, is an elastomeric material such as a polyurethane, more particularly a polycarbonate polyurethane (e.g., an aromatic polycarbonate polyurethane) or polysiloxane polyurethane; a silicone; a polyolefin such as polyethylene; or a hydrogel. Desirably, the second material has a hardness of at least about 75A Durometer (Shore scale), more particularly, a hardness ranging from about 80A to about 65D.
In one embodiment of a central body for use in an endoprosthesis in connection with articulating shells, the central body contains a central component formed from the second material, disposed between two outer components formed from the first material. These outer components form wear resistant “caps” that provide wear surfaces for contact with the articulating shells. The thickness of the caps is sufficient to provide adequate useful life for the endoprosthesis, but not so thick as to significantly decrease the level of elasticity provided by the resilient second material. Typical thicknesses for the layers of first material range from about 0.25 mm to about 7 mm.
The caps desirably have a geometry that provides a smooth outer bearing surface for contact with the shells of the endoprosthesis, as indicated above. In addition, the cap geometry may contain elements that help to retain the cap in ideal alignment with the central component (i.e., the elastomeric “core” of the central body), or may be simply be inset into the central component and held in place by compressive forces (either those exerted on the cap by the resilient material surrounding the inset, or those exerted on the cap by the shells of the endoprosthesis or both).
These concepts can be further understood by reference to the drawings.
The distance d between the closest portions (as illustrated, the edges) of first cap 20 and second cap 30 should be sufficient that the amount of resilient second material therebetween can provide the desired height under expected load and compression conditions before the edges of the caps come into contact. As illustrated, inner surfaces 60 of caps 20 and 30 are curved, and the radius of this curvature may be the same as or different from that of the outer surfaces 70 of the caps 20, 30, but corresponds closely to the radius of curvature of the surface of core 40. As compressive stress is exerted against the outer surfaces of caps 20, 30, this stress will be transferred to the core 40. Core 40 will tend to respond to this stress by undergoing strain. Because the second material forming core 40 is resilient, some of this strain will be in the lateral direction, toward the edges of the core. The curved inner surfaces of the stiffer caps tend to limit this lateral strain, and to resist shear stresses in the core.
a and 3b also illustrate another optional feature of the invention, namely that the thickness of caps 20, 30 can vary in the radial direction. As illustrated, caps 20, 30 are thicker near central openings 50, 55 than near the peripheral edge. Thicker caps can provide an increase in durability and wear resistance, but will likely result in a decrease in resiliency, since for a given volume of central body and a given second material, there will be a smaller amount of second material present to provide resiliency if the thickness of the caps in increased. Caps that are thicker toward the central openings 50, 55 provide increased durability in areas of the device more likely to come into contact with the shell or retaining devices of the endoprosthesis. By making the caps thinner toward their periphery, a greater proportion of the thickness of the endoprosthesis is made of the more resilient second material in regions of the endoprosthesis where avoiding contact between the caps is of greater concern.
In another embodiment of the invention, the central body can contain a central component formed from the first material, disposed between outer components formed from the second material. Such an arrangement might be desirable, e.g., in a device where a portion of the central component extends radially from the center of the endoprosthesis, forming a circumferential ridge, in order to limit or prevent contact between the edges of the shells, e.g., when the endoprosthesis meets or exceeds its desirable range of motion. In such a device, the radial extension of the central component will contact the shell edge(s), which can result in wear. Making some or all of this portion of the device from a wear resistant material (i.e., the first material) can limit or avoid generation of wear debris that results from subjecting the endoprosthesis to extreme range of motion.
In the embodiments of the invention disclosed above, the central body can be made by a variety of techniques, such as insert molding, injection molding and machining and assembly, and the like. The design of the central body, as well as the difference in physical properties of materials, makes insert molding particularly attractive. For example, the embodiment of the invention wherein wear resistant caps are to be disposed around an elastomeric core can be made by forming the end caps using any acceptable technique (e.g., injection molding followed by machining), disposing the harder, higher melting caps into an insert mold, and injecting molten elastomeric material into the mold cavity between the caps
As an example, UHMWPE is formed into caps, which are machined as necessary to obtain the desired shape, and introduced into the mold cavity of an injection molding machine. The mold is then closed, and polycarbonate polyurethane material (e.g., Chronoflex C80A) is introduced into the mold cavity between the caps at a temperature of about 450° F. and a range of pressure correlating the geometry of the cavity and rate of injection. Temperature in the mold is monitored and adjusted as needed, and after approximately 1-2 minutes, the mold is opened and the central body is withdrawn and any flashing removed. The resulting central body can then be assembled into an endoprosthesis by disposing it between two compatibly shaped endplate shells.
The endoprosthesis can be provided as part of a kit, which may include one more surgical instruments designed to locate and prepare the joint space, and implant the endoprosthesis therein. Suitable instruments for preparing an intervertebral disc space and implanting therein an intervertebral endoprosthesis are disclosed in U.S. Ser. No. 09/923,891, filed Aug. 7, 2001. The surgical method, as described in the cited patent application, includes precisely locating the site of the endoprosthesis, performing at least a partial discectomy, preparing the endplates of the vertebral bodies to correspond to the geometry of the outer surface of the shell, and implanting the endoprosthesis. Similar procedures can be used to implant endoprostheses in other joints.
This application is a continuation-in-part of U.S. application Ser. No. 09/923,891, filed Aug. 7, 2001 now U.S. Pat. No. 6,949,105, which is a continuation-in-part of U.S. application Ser. No. 09/783,860, filed Feb. 13, 2001, now abandoned which claims benefit to U.S. application Ser. Nos. 60/223,863 filed Aug. 8, 2000 and 60/265,218 filed Jan. 31, 2001. This application is also a continuation-in-part of U.S. application Ser. No. 09/924,298, filed Aug. 8, 2001, which is a continuation-in-part of U.S. application Ser. No. 09/783,910, filed Feb. 13, 2001 now abandoned, which claims benefit to U.S. application Ser. No. 60/223,863 filed Aug. 8, 2000 and 60/265,218 filed Jan. 31, 2001. The entire contents of Ser. Nos. 09/924,298 and 09/923,891 are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2677369 | Knowles | May 1954 | A |
3486505 | Morrison | Dec 1969 | A |
3574374 | Keller et al. | Apr 1971 | A |
3864758 | Yakich | Feb 1975 | A |
3875595 | Froning | Apr 1975 | A |
3876728 | Stubstad | Apr 1975 | A |
4023572 | Weigand et al. | May 1977 | A |
4116200 | Braun et al. | Sep 1978 | A |
4179810 | Kirsch | Dec 1979 | A |
4193139 | Walker | Mar 1980 | A |
4309777 | Patil | Jan 1982 | A |
4313232 | Habal et al. | Feb 1982 | A |
4314380 | Miyata et al. | Feb 1982 | A |
4349921 | Kuntz | Sep 1982 | A |
4359318 | Gittleman | Nov 1982 | A |
4599086 | Doty | Jul 1986 | A |
4645507 | Engelbrecht et al. | Feb 1987 | A |
4714469 | Kenna | Dec 1987 | A |
4743256 | Brantigan | May 1988 | A |
4757983 | Ray et al. | Jul 1988 | A |
4759766 | Buettner-Janz et al. | Jul 1988 | A |
4759769 | Hedman et al. | Jul 1988 | A |
4766328 | Yang | Aug 1988 | A |
4777942 | Frey et al. | Oct 1988 | A |
4800639 | Frey et al. | Jan 1989 | A |
4834757 | Brantigan | May 1989 | A |
4863476 | Shepperd | Sep 1989 | A |
4863477 | Monson | Sep 1989 | A |
4874389 | Downey | Oct 1989 | A |
4878915 | Brantigan | Nov 1989 | A |
4887595 | Heinig et al. | Dec 1989 | A |
4904260 | Ray et al. | Feb 1990 | A |
4904261 | Dove et al. | Feb 1990 | A |
4908032 | Keller | Mar 1990 | A |
4908036 | Link et al. | Mar 1990 | A |
4911718 | Lee et al. | Mar 1990 | A |
4917704 | Frey et al. | Apr 1990 | A |
4932969 | Frey et al. | Jun 1990 | A |
4932975 | Main et al. | Jun 1990 | A |
4946378 | Hirayama et al. | Aug 1990 | A |
4955908 | Frey et al. | Sep 1990 | A |
4978355 | Frey et al. | Dec 1990 | A |
4990163 | Ducheyne et al. | Feb 1991 | A |
4997432 | Keller | Mar 1991 | A |
5002576 | Fuhrmann et al. | Mar 1991 | A |
5015247 | Michelson | May 1991 | A |
5035716 | Downey | Jul 1991 | A |
5047055 | Bao et al. | Sep 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5059194 | Michelson | Oct 1991 | A |
5062845 | Kuslich et al. | Nov 1991 | A |
5071437 | Steffee | Dec 1991 | A |
5080662 | Paul | Jan 1992 | A |
5084048 | Jacob et al. | Jan 1992 | A |
5108438 | Stone | Apr 1992 | A |
5122130 | Keller | Jun 1992 | A |
5123926 | Pisharodi | Jun 1992 | A |
5171280 | Baumgartner | Dec 1992 | A |
5171281 | Parsons et al. | Dec 1992 | A |
5176708 | Frey et al. | Jan 1993 | A |
5192326 | Bao et al. | Mar 1993 | A |
5192327 | Brantigan | Mar 1993 | A |
5201749 | Sachse et al. | Apr 1993 | A |
5207680 | Dietz et al. | May 1993 | A |
5219363 | Crowninshield et al. | Jun 1993 | A |
5234431 | Keller | Aug 1993 | A |
5236460 | Barber | Aug 1993 | A |
5246458 | Graham | Sep 1993 | A |
5257998 | Ota et al. | Nov 1993 | A |
5258031 | Salib et al. | Nov 1993 | A |
5261911 | Carl | Nov 1993 | A |
5261913 | Marnay | Nov 1993 | A |
5306308 | Gross et al. | Apr 1994 | A |
5314477 | Marnay | May 1994 | A |
5314478 | Oka et al. | May 1994 | A |
5320644 | Baumgartner | Jun 1994 | A |
5370697 | Baumgartner | Dec 1994 | A |
5383933 | Keller | Jan 1995 | A |
5389101 | Heilbrun et al. | Feb 1995 | A |
5401269 | Buttner-Janz et al. | Mar 1995 | A |
5403314 | Currier | Apr 1995 | A |
5425772 | Brantigan | Jun 1995 | A |
5425773 | Boyd et al. | Jun 1995 | A |
5443514 | Steffee | Aug 1995 | A |
5456719 | Keller | Oct 1995 | A |
5458638 | Kuslich et al. | Oct 1995 | A |
5458642 | Beer et al. | Oct 1995 | A |
5484437 | Michelson | Jan 1996 | A |
5486180 | Dietz et al. | Jan 1996 | A |
5489307 | Kuslich et al. | Feb 1996 | A |
5489308 | Kuslich et al. | Feb 1996 | A |
5496318 | Howland et al. | Mar 1996 | A |
5507816 | Bullivant | Apr 1996 | A |
5514180 | Heggeness et al. | May 1996 | A |
5527315 | Jeanson et al. | Jun 1996 | A |
5534005 | Tokish, Jr. et al. | Jul 1996 | A |
5534028 | Bao et al. | Jul 1996 | A |
5534029 | Shima | Jul 1996 | A |
5534030 | Navarro et al. | Jul 1996 | A |
5545229 | Parsons et al. | Aug 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5556431 | Buttner-Janz | Sep 1996 | A |
5562738 | Boyd et al. | Oct 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5593409 | Michelson | Jan 1997 | A |
5593445 | Waits | Jan 1997 | A |
5609636 | Kohrs et al. | Mar 1997 | A |
5641323 | Caldarise | Jun 1997 | A |
5645597 | Krapiva | Jul 1997 | A |
5645598 | Brosnahan | Jul 1997 | A |
5649926 | Howland | Jul 1997 | A |
5653714 | Dietz et al. | Aug 1997 | A |
5658285 | Marnay et al. | Aug 1997 | A |
5662158 | Caldarise | Sep 1997 | A |
5674294 | Bainville et al. | Oct 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5674296 | Bryan et al. | Oct 1997 | A |
5676701 | Yuan et al. | Oct 1997 | A |
5683464 | Wagner et al. | Nov 1997 | A |
5702450 | Bisserie | Dec 1997 | A |
5713899 | Marnay et al. | Feb 1998 | A |
5716415 | Steffee | Feb 1998 | A |
5720748 | Kuslich et al. | Feb 1998 | A |
5722977 | Wilhelmy | Mar 1998 | A |
5723013 | Jeanson et al. | Mar 1998 | A |
5741253 | Michelson | Apr 1998 | A |
5782830 | Farris | Jul 1998 | A |
5782832 | Larsen et al. | Jul 1998 | A |
5797909 | Michelson | Aug 1998 | A |
5824093 | Ray et al. | Oct 1998 | A |
5824094 | Serhan et al. | Oct 1998 | A |
5865846 | Bryan et al. | Feb 1999 | A |
5865848 | Baker | Feb 1999 | A |
5868796 | Buechel et al. | Feb 1999 | A |
5885300 | Tokuhashi et al. | Mar 1999 | A |
5888197 | Mulac et al. | Mar 1999 | A |
5888226 | Rogozinski | Mar 1999 | A |
5897087 | Farley | Apr 1999 | A |
5902233 | Farley et al. | May 1999 | A |
5928284 | Mehdizadeh | Jul 1999 | A |
5947971 | Kuslich et al. | Sep 1999 | A |
5964761 | Kambin | Oct 1999 | A |
5976187 | Richelsoph | Nov 1999 | A |
5984865 | Farley et al. | Nov 1999 | A |
5989291 | Ralph et al. | Nov 1999 | A |
6001130 | Bryan et al. | Dec 1999 | A |
6017008 | Farley | Jan 2000 | A |
6022376 | Assell | Feb 2000 | A |
6033363 | Farley et al. | Mar 2000 | A |
6059790 | Sand et al. | May 2000 | A |
6059829 | Schlapfer et al. | May 2000 | A |
6063121 | Xavier et al. | May 2000 | A |
6066174 | Farris | May 2000 | A |
6080155 | Michelson | Jun 2000 | A |
6083228 | Michelson | Jul 2000 | A |
6086595 | Yonemura et al. | Jul 2000 | A |
6096038 | Michelson | Aug 2000 | A |
6096084 | Townley | Aug 2000 | A |
6132465 | Ray et al. | Oct 2000 | A |
6139579 | Steffee et al. | Oct 2000 | A |
6146421 | Gordon et al. | Nov 2000 | A |
6156067 | Bryan et al. | Dec 2000 | A |
6162252 | Kuras et al. | Dec 2000 | A |
6179874 | Cauthen | Jan 2001 | B1 |
6228022 | Friesem et al. | May 2001 | B1 |
6228026 | Rull et al. | May 2001 | B1 |
6231609 | Mehdizadeh | May 2001 | B1 |
6261293 | Nicholson et al. | Jul 2001 | B1 |
6283998 | Eaton | Sep 2001 | B1 |
6290726 | Pope et al. | Sep 2001 | B1 |
6348071 | Steffee et al. | Feb 2002 | B1 |
6395032 | Gauchet | May 2002 | B1 |
6395034 | Suddaby | May 2002 | B1 |
6402785 | Zdeblick et al. | Jun 2002 | B1 |
6419706 | Graf | Jul 2002 | B1 |
6436101 | Hamada | Aug 2002 | B1 |
6517544 | Michelson | Feb 2003 | B1 |
6533817 | Norton et al. | Mar 2003 | B1 |
6533818 | Weber et al. | Mar 2003 | B1 |
6575899 | Foley et al. | Jun 2003 | B1 |
6582466 | Gauchet | Jun 2003 | B1 |
6682562 | Viart et al. | Jan 2004 | B2 |
7025787 | Bryan et al. | Apr 2006 | B2 |
20020151901 | Bryan et al. | Oct 2002 | A1 |
20020183848 | Ray et al. | Dec 2002 | A1 |
20040158254 | Eisermann | Aug 2004 | A1 |
Number | Date | Country |
---|---|---|
2263842 | Jul 1974 | DE |
2804936 | Aug 1979 | DE |
30 23 353 | Apr 1981 | DE |
3343863 | Jun 1985 | DE |
37 41 493 | Jun 1989 | DE |
9000094.3 | Jan 1990 | DE |
90 00 094.3 | Mar 1991 | DE |
196 53 580 | Jun 1998 | DE |
0176728 | Apr 1986 | EP |
0 560 140 | Sep 1993 | EP |
2805985 | Mar 2000 | FR |
895433 | Jan 1982 | SU |
1560184 | Apr 1990 | SU |
9316656 | Sep 1993 | WO |
WO 0004839 | Feb 2000 | WO |
WO 0004851 | Feb 2000 | WO |
WO 0013619 | Mar 2000 | WO |
WO 0013620 | Mar 2000 | WO |
WO 02 11633 | Feb 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20040054411 A1 | Mar 2004 | US |
Number | Date | Country | |
---|---|---|---|
60265218 | Jan 2001 | US | |
60223863 | Aug 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09923891 | Aug 2001 | US |
Child | 10600052 | US | |
Parent | 09783860 | Feb 2001 | US |
Child | 09923891 | US | |
Parent | 10600052 | US | |
Child | 09923891 | US | |
Parent | 09924298 | Aug 2001 | US |
Child | 10600052 | US | |
Parent | 09783910 | Feb 2001 | US |
Child | 09924298 | US |